Generix Group annual ebitda
2021
2022
Generix Group EBITDA Growth & History (GENX)
Generix Group's calculated EBITDA was €11.2M for fiscal 2022.
View full Generix Group company overviewGenerix Group annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2022 | 2022-03-31 | €11.2M | −€435,000 | −3.73% |
| 2021 | 2021-03-31 | €11.7M | — | — |
Generix Group ebitda trends
Between the periods ended 2021-03-31 and 2022-03-31, Generix Group's ebitda decreased from €11.7M to €11.2M, a change of −€435,000.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Generix Group source filings ↗